These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Positivity of patch tests in cutaneous reaction to diclofenac. Two case reports. Romano A; Pietrantonio F; Di Fonso M; Garcovich A; Chiarelli C; Venuti A; Barone C Allergy; 1994 Jan; 49(1):57-9. PubMed ID: 8198241 [TBL] [Abstract][Full Text] [Related]
3. Delayed hypersensitivity reactions to diclofenac. Klingenberg RD; Bassukas ID; Homann N; Stange EF; Ludwig D Allergy; 2003 Oct; 58(10):1076-7. PubMed ID: 14510735 [No Abstract] [Full Text] [Related]
4. Delayed hypersensitivity to diclofenac: a report on two cases. Romano A; Quaratino D; Papa G; Di Fonso M; Artesani MC; Venuti A Ann Allergy Asthma Immunol; 1998 Oct; 81(4):373-5. PubMed ID: 9809503 [TBL] [Abstract][Full Text] [Related]
5. Allergic contact dermatitis from topical diclofenac. Gebhardt M; Reuter A; Knopf B Contact Dermatitis; 1994 Mar; 30(3):183-4. PubMed ID: 8187529 [No Abstract] [Full Text] [Related]
6. Delayed hypersensitivity to stepronin: a case report. Romano A; Pietrantonio F; di Fonso M; Pocobelli D; Venuti A Contact Dermatitis; 1993 Sep; 29(3):166. PubMed ID: 8222642 [No Abstract] [Full Text] [Related]
9. Delayed-type hypersensitivity to mofebutazone underlying a severe drug reaction. Walchner M; Rueff F; Przybilla B Contact Dermatitis; 1997 Jan; 36(1):54-5. PubMed ID: 9034692 [No Abstract] [Full Text] [Related]
10. Delayed-type hypersensitivity to protamine as a complication of insulin therapy. Raap U; Liekenbröcker T; Kapp A; Wedi B Contact Dermatitis; 2005 Jul; 53(1):57-8. PubMed ID: 15982236 [No Abstract] [Full Text] [Related]
11. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration. Irion R; Gall H; Peter RU Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948 [No Abstract] [Full Text] [Related]
12. Delayed hypersensitivity reaction to heparin in a pregnant woman. Sanders MN; Bernhisel-Broadbent J; Staker LV Int J Dermatol; 1995 Jun; 34(6):443-4. PubMed ID: 7657449 [No Abstract] [Full Text] [Related]
13. Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 cases. Borgemeester RWK; van Laar T; Schuttelaar MLA Contact Dermatitis; 2018 Nov; 79(5):316-318. PubMed ID: 30123968 [No Abstract] [Full Text] [Related]
14. Delayed-type hypersensitivity to mepivacaine with cross-reaction to lidocaine. Sanchez-Morillas L; Martinez JJ; Martos MR; Gomez-Tembleque P; Andres ER Contact Dermatitis; 2005 Dec; 53(6):352-3. PubMed ID: 16364127 [No Abstract] [Full Text] [Related]
19. Biting down on the truth: A case of a delayed hypersensitivity reaction to lidocaine. Dickison P; Smith SD Australas J Dermatol; 2019 Feb; 60(1):66-67. PubMed ID: 29961943 [No Abstract] [Full Text] [Related]
20. Allergic urticarial rash from oral codeine. de Groot AC; Conemans J Contact Dermatitis; 1986 Apr; 14(4):209-14. PubMed ID: 2941218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]